Last reviewed 2026-03-25 · How we verify

Ovarian Cancer

Approved treatments

No approved treatments tracked yet.

Pipeline

• Pegylated Liposomal Doxorubicin (PLD) · Pfizer Inc. — discontinued

Clinical guidelines

• FDA label — 2L
  DOXIL liposomal infusion is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after platinum-based chemotherapy.
• FDA label — 2L
  DOXIL liposomal infusion is indicated for the treatment of AIDS-related Kaposi's sarcoma in patients after failure of prior systemic chemotherapy or intolerance to such therapy.

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

• Ovarian Cancer treatment landscape brief
• Ovarian Cancer treatment updates RSS